Rapid iPSC inclusionopathy models shed light on formation, consequence and molecular subtype of α-synuclein inclusions
Author:
Lam IsabelORCID, Ndayisaba Alain, Lewis Amanda J., Fu YuHong, Sagredo Giselle T., Zaccagnini Ludovica, Sandoe Jackson, Sanz Ricardo L., Vahdatshoar Aazam, Martin Timothy D., Morshed Nader, Ichihashi Toru, Tripathi Arati, Ramalingam Nagendran, Oettgen-Suazo Charlotte, Bartels Theresa, Schäbinger Max, Hallacli Erinc, Jiang Xin, Verma Amrita, Tea Challana, Wang Zichen, Hakozaki Hiroyuki, Yu Xiao, Hyles Kelly, Park Chansaem, Theunissen Thorold W., Wang Haoyi, Jaenisch Rudolf, Lindquist Susan, Stevens BethORCID, Stefanova Nadia, Wenning Gregor, Luk Kelvin C.ORCID, Pernaute Rosario Sanchez, Gómez-Esteban Juan Carlos, Felsky Daniel, Kiyota Yasujiro, Sahni Nidhi, Yi S. Stephen, Chung Chee-Yeun, Stahlberg HenningORCID, Ferrer Isidro, Schöneberg Johannes, Elledge Stephen J., Dettmer Ulf, Halliday Glenda M.ORCID, Bartels Tim, Khurana Vikram
Abstract
ABSTRACTIntracellular inclusions accompanying neurodegeneration are histopathologically and ultrastructurally heterogeneous but the significance of this heterogeneity is unclear. iPSC models, while promising for disease modeling, do not form inclusions in a reasonable timeframe and suffer from limited tractability. Here, we developed an iPSC toolbox utilizing piggyBac-based or targeted transgenes to rapidly induce CNS cells with concomitant expression of aggregation-prone proteins. This system is amenable to screening and longitudinal tracking at single-cell and single-inclusion resolution. For proof-of-principle, cortical neuron α-synuclein “inclusionopathy” models were engineered to form inclusions through exogenous seeding or α-synuclein mutation. These models recapitulated known fibril- and lipid-rich inclusion subtypes, uncovering dynamic interactions between them, and refined the classification of inclusions in postmortem brain. Genetic-modifier and protein-interaction screens pinpointed proteins like RhoA whose sequestration into specific inclusion subtypes is likely to be toxic. This iPSC platform should enhance our understanding of proteinaceous pathologies in neurodegeneration and facilitate therapeutics development.
Publisher
Cold Spring Harbor Laboratory
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|